Back
EyePoint Pharmaceuticals Quote, Financials, Valuation and Earnings
Sell
50
EYPT
EyePoint Pharmaceuticals
Last Price:
11.83
Seasonality Move:
6.87%
7 Day Trial
ALL ACCESS PASS
$
7
EyePoint Pharmaceuticals Price Quote
$11.83
-0.01 (-5.51%)
(Updated: May 18, 2024 at 5:42 AM ET)
EyePoint Pharmaceuticals Key Stats
Sell
50
EyePoint Pharmaceuticals (EYPT)
is a Sell
Day range:
$11.81 - $12.49
52-week range:
$5.67 - $30.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
10.12
P/B ratio:
2.47%
Volume:
1M
Avg. volume:
1.4M
1-year change:
84.71%
Market cap:
$616.7M
Revenue:
$46M
EPS:
$-1.81
How Much Does EyePoint Pharmaceuticals Make?
-
How Much Are EyePoint Pharmaceuticals's Sales Annually?
EYPT Revenues are $46M -
How Much Profit Does EyePoint Pharmaceuticals's Make A Year?
EYPT net income is -$70.8M
Is EyePoint Pharmaceuticals Growing As A Company?
-
What Is EyePoint Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.52% -
What Is EyePoint Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
EyePoint Pharmaceuticals Stock Price Performance
-
Did EyePoint Pharmaceuticals Stock Go Up Last Month?
EyePoint Pharmaceuticals share price went down by -43.46% last month -
Did EYPT's Share Price Rise Over The Last Year?
EYPT share price rose by 84.71% over the past 1 year
What Is EyePoint Pharmaceuticals 52-Week High & Low?
-
What Is EyePoint Pharmaceuticals’s 52-Week High Share Price?
EyePoint Pharmaceuticals has traded as high as $30.99 over the past 52 weeks -
What Is EyePoint Pharmaceuticals’s 52-Week Low Share Price?
EyePoint Pharmaceuticals has traded as low as $5.67 over the past 52 weeks
EyePoint Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy EyePoint Pharmaceuticals?
-
How Much Debt Does EyePoint Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does EyePoint Pharmaceuticals Have?
Cash and short term investments quarterly total is $299.3M -
What Is EyePoint Pharmaceuticals’s Book Value Per Share?
Book value per share is 5.01
Is EyePoint Pharmaceuticals Cash Flow Positive?
-
What Is EYPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$12.5M -
What Is EyePoint Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $192.3M -
What Is EyePoint Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$14.6M
EyePoint Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
EYPT return on invested capital is -52.95% -
What Is EyePoint Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -33.59% -
What Is EYPT Return On Equity?
ROE is a measure of profitability and is -55.53%
EyePoint Pharmaceuticals Earnings Date & Stock Price
-
What Is EyePoint Pharmaceuticals's Stock Price Today?
A single share of EYPT can be purchased today for 11.84 -
What Is EyePoint Pharmaceuticals’s Stock Symbol?
EyePoint Pharmaceuticals trades on the nasdaq under the ticker symbol: EYPT -
When Is EyePoint Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for EyePoint Pharmaceuticals is scheduled on August 2, 2024 -
When Is EYPT's next ex-dividend date?
EyePoint Pharmaceuticals's next ex-dividend date is May 27, 2020 -
How To Buy EyePoint Pharmaceuticals Stock?
You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
EyePoint Pharmaceuticals Competitors
-
Who Are EyePoint Pharmaceuticals's Competitors?
Below is a list of companies who compete with EyePoint Pharmaceuticals or are related in some way:
EyePoint Pharmaceuticals Dividend Yield
Data Unavailable
EyePoint Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -29.54% |
| Revenue: | 52.08% | 27.9% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 39.11 |
| Upside from Last Price: | 230.33% |